Here, the ratio of p-PP2A/PP2A that inversely correlated the activity of PP2A in vivo was significantly lower in the cortex of Se-FA-treated mice than in the cortex of AD mice (Figure 5g,h), suggesting that Se-FA reduces tau hyperphosphorylation by enhancing the activity of PP2A. Here, MAPT is linked to Alzheimer disease.